|
|
|
June 20, 2002 Personal Finance
Biotech Bargains? Sectoral Asset Management's Michael Sjostrom thinks some stocks in this beaten-down group look attractive now, including Gilead Sciences and InterMune These clips require RealPlayer Download RealPlayer here |
| Copyright 2001-2002, Bloomberg L.P. Terms of Use | Privacy Policy | Video comments: video@businessweek.com |